Broadcast Date: 
  • Time: 

Join us for an installment of our Bionano In Motion webinar series as our speakers delve into immunotherapies and the emerging role of optical genome mapping (OGM) in assessing genome integrity as part of CAR-T cell therapy research.

In this webinar, Dr. Alex Hastie,  VP of Clinical and Scientific Affairs at Bionano, will provide an introduction on the utility of OGM in cell and gene therapy. Dr. Rashmi Kanagal-Shamanna, Director of the Molecular Diagnostic Lab at MD Anderson Cancer Center, will then present her lab’s experience using OGM with immunotherapies, focusing on CAR-T therapy. Don’t miss this opportunity to engage with these leading minds in the field and stay at the forefront of research advancements that are driving us closer to more effective and personalized cancer treatments.

A live Q&A session followed the presentations, offering a chance to pose questions to our expert panelists.

Produced with support from:

Bionano logo
Alex Hastie
Alex Hastie, PhD
VP, Clinical and Scientific Affairs
Bionano Genomics
Rashmi Kanagal-Shamanna
Rashmi Kanagal-Shamanna, MD
Director, Molecular Diagnostic Lab
MD Anderson Cancer Center
Previous articleSynthego, Collaborate on Multiplexed Cell Engineering Platform
Next articleNaked Mole Rat Longevity Gene Lengthens Lifespan of Mice